The Genetic Determinants of Innate Immunity and Host Defense
先天免疫和宿主防御的遗传决定因素
基本信息
- 批准号:7594015
- 负责人:
- 金额:$ 102.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AccountingAspergillosisAspergillus fumigatusAtherosclerosisBacteremiaBiological ModelsBreathingCD14 AntigenCaenorhabditis elegansCultured CellsGene ExpressionGenesGeneticGenetic DeterminismGenetic PolymorphismGenomicsGoalsGram-Positive BacteriaHost DefenseHumanImmuneImmune responseIndividualInfectionInvasiveLifeLipopolysaccharidesLungMusNatural ImmunityNematodaOrganismOutcomePhenotypePhysiologicalPredispositionRNA InterferenceResearchRoleSepsisSeveritiesStaphylococcus aureusStimulusTLR4 geneTechniquesTestingToxinVariantmicrobialnovelpathogenpositional cloningprogramsresponsetissue culturetoll-like receptor 4
项目摘要
The goals of this project are to identify novel genes involved in innate immunity and to determine if polymorphisms in some of these genes regulate the innate immune response to lipopolysaccharide (LPS), Staphylococcus aureus, Gram negative sepsis, and Aspergillus fumigatus infection in humans.
We have previously shown that polymorphisms in TLR4, the receptor for LPS, are associated with hyporesponsiveness to inhaled LPS in mice and humans. We have also shown that these same polymorphisms predispose humans to Gram negative sepsis and protect them from atherosclerosis. However, our previous findings also demonstrate that sequence variants of TLR4 account for only a portion of the LPS phenotype in either mice or humans and that other genes are also involved in regulating the response to LPS.
The role of host susceptibility in the initiation and severity of infections caused by Gram negative and Gram positive bacteria is incompletely understood. The overall goal of our sepsis project is to further understand why some individuals develop infection, and of those with bacteremia, why only some go on to have adverse outcomes. Similarly, very little is known about the hosts innate immune response to Aspergillus fumigatus, a fungal pathogen that causes invasive pulmonary aspergillosis in immunocompromized hosts.
The overall hypothesis of this research program is that polymorphisms of genes identified either by genetic or genomic techniques following a challenge with a microbial toxin or a live organism in model systems (mice, C. elegans, and cell culture) regulate the pathophysiologic response to innate immune stimuli in humans. To test this hypothesis, gene expression and positional cloning studies will be conducted in mice and their genetic relevance will be tested in humans. We will also use RNA interference (RNAi) in mammalian tissue culture and the nematode C. elegans to test the physiologic and biologic importance of these genes.
该项目的目标是识别与先天免疫有关的新基因,并确定其中一些基因的多态性是否调节人类对内毒素(LPS)、金黄色葡萄球菌、革兰氏阴性败血症和烟曲霉感染的先天免疫反应。
我们之前已经证明,在小鼠和人类中,内毒素受体TLR4的多态与对吸入内毒素的低反应有关。我们还表明,这些相同的基因多态性使人类容易患上革兰氏阴性脓毒症,并保护他们免受动脉粥样硬化的影响。然而,我们以前的发现也表明,TLR4的序列变体只占小鼠或人类的部分内毒素表型,其他基因也参与调节对内毒素的反应。
宿主易感性在革兰氏阴性菌和革兰氏阳性菌引起的感染的起始和严重程度中的作用尚不完全清楚。我们败血症项目的总体目标是进一步了解为什么有些人会发生感染,而那些患有菌血症的人,为什么只有一些人会有不良后果。同样,对宿主对烟曲霉的先天免疫反应知之甚少。烟曲霉是一种真菌病原体,会在免疫受损的宿主中导致侵袭性肺曲霉病。
这个研究项目的总体假设是,在用微生物毒素或模型系统(小鼠、线虫和细胞培养)中的活生物体挑战后,通过遗传或基因组技术确定的基因的多态调节人类对先天性免疫刺激的病理生理反应。为了验证这一假设,将在小鼠身上进行基因表达和位置克隆研究,并将在人类身上测试它们的遗传相关性。我们还将在哺乳动物组织培养和线虫中使用RNA干扰(RNAi)来测试这些基因的生理和生物学重要性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Schwartz其他文献
David Schwartz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Schwartz', 18)}}的其他基金
Development of a Multi-Panel Multiplex Immunofluorescence Breast Cancer Immunophenotyping Assay
多组多重免疫荧光乳腺癌免疫表型分析的开发
- 批准号:
9151812 - 财政年份:2015
- 资助金额:
$ 102.36万 - 项目类别:
Genetic/Biological Determinants of Environmental Disease
环境疾病的遗传/生物决定因素
- 批准号:
7174902 - 财政年份:
- 资助金额:
$ 102.36万 - 项目类别:
The Genetic and Biological Determinants of Environmental Airway Disease
环境气道疾病的遗传和生物决定因素
- 批准号:
7734544 - 财政年份:
- 资助金额:
$ 102.36万 - 项目类别:
Genetic Determinants of Innate Immunity and Host Defense
先天免疫和宿主防御的遗传决定因素
- 批准号:
7174903 - 财政年份:
- 资助金额:
$ 102.36万 - 项目类别:
The Genetic Determinants of Innate Immunity and Host Def
先天免疫和宿主防御的遗传决定因素
- 批准号:
7330694 - 财政年份:
- 资助金额:
$ 102.36万 - 项目类别:
The Genetic Determinants of Innate Immunity and Host Defense
先天免疫和宿主防御的遗传决定因素
- 批准号:
7734545 - 财政年份:
- 资助金额:
$ 102.36万 - 项目类别:
The Genetic Determinants of Interstitial Lung Disease
间质性肺病的遗传决定因素
- 批准号:
7734546 - 财政年份:
- 资助金额:
$ 102.36万 - 项目类别:
The Genetic Determinants of Interstitial Lung Disease
间质性肺病的遗传决定因素
- 批准号:
7594016 - 财政年份:
- 资助金额:
$ 102.36万 - 项目类别:
相似海外基金
Development of a new treatment strategy for pulmonary aspergillosis by innate immune effector cells
先天免疫效应细胞开发肺曲霉病新治疗策略
- 批准号:
23K07941 - 财政年份:2023
- 资助金额:
$ 102.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis
开发侵袭性肺曲霉病的急性髓系白血病小鼠模型,以深入了解白血病及其治疗在曲霉病病理学中的作用
- 批准号:
10524878 - 财政年份:2022
- 资助金额:
$ 102.36万 - 项目类别:
The mechanism of secondary pulmonary aspergillosis after viral infection
病毒感染后继发肺曲霉菌病的机制
- 批准号:
22K08617 - 财政年份:2022
- 资助金额:
$ 102.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis
开发侵袭性肺曲霉病的急性髓系白血病小鼠模型,以深入了解白血病及其治疗在曲霉病病理学中的作用
- 批准号:
10622540 - 财政年份:2022
- 资助金额:
$ 102.36万 - 项目类别:
Regulation of Inflammatory Pathology in Invasive Aspergillosis
侵袭性曲霉病炎症病理学的调节
- 批准号:
10427455 - 财政年份:2021
- 资助金额:
$ 102.36万 - 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10835161 - 财政年份:2021
- 资助金额:
$ 102.36万 - 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10449394 - 财政年份:2021
- 资助金额:
$ 102.36万 - 项目类别:
Regulation of Inflammatory Pathology in Invasive Aspergillosis
侵袭性曲霉病炎症病理学的调节
- 批准号:
10286538 - 财政年份:2021
- 资助金额:
$ 102.36万 - 项目类别:
Influenza Attenuates Innate Pulmonary Host Defense against Invasive Pulmonary Aspergillosis
流感削弱肺宿主对侵袭性肺曲霉病的先天防御
- 批准号:
10651832 - 财政年份:2021
- 资助金额:
$ 102.36万 - 项目类别:
Is the excess mortality amongst tuberculosis survivors explained by Chronic Pulmonary Aspergillosis? Investigating burden, diagnosis, and therapy
结核病幸存者死亡率过高是否可以用慢性肺曲霉病来解释?
- 批准号:
nhmrc : 1196100 - 财政年份:2021
- 资助金额:
$ 102.36万 - 项目类别:
Investigator Grants